Next Article in Journal
A Novel LncRNA MSTRG.310246.1 Promotes Differentiation and Thermogenesis in Goat Brown Adipocytes
Next Article in Special Issue
Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary Breast and Colorectal Cancer Patients
Previous Article in Journal
Mutational Spectrum, Ocular and Olfactory Phenotypes of CNGB1-Related RP-Olfactory Dysfunction Syndrome in a Multiethnic Cohort
Previous Article in Special Issue
Mutational Spectrum of the ABCA12 Gene and Genotype–Phenotype Correlation in a Cohort of 64 Patients with Autosomal Recessive Congenital Ichthyosis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 14
Issue 4
10.3390/genes14040831
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Rare Coding Variants in Patients with Non-Syndromic Vestibular Dysfunction

by
Angelo Augusto M. Sumalde
1,2,
Melissa A. Scholes
1,3,4,
Olivia A. Kalmanson
1,
Elizabeth A. Terhune
5,
Lidia Frejo
6,7,
Cambria I. Wethey
5,
Pablo Roman-Naranjo
6,7,
Patrick M. Carry
5,8,
Samuel P. Gubbels
1,
Jose A. Lopez-Escamez
6,7,9,
Nancy Hadley-Miller
5,8 and
Regie Lyn P. Santos-Cortez
1,10,*
1
Department of Otolaryngology-Head and Neck Surgery, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
2
Department of Otolaryngology-Head and Neck Surgery, University of the Philippines Manila College of Medicine, Philippine General Hospital, Manila 1000, Philippines
3
Department of Pediatric Otolaryngology, Children’s Hospital Colorado, Aurora, CO 80045, USA
4
Department of Otolaryngology-Head and Neck Surgery, University of Mississippi Medical Center, Jackson, MS 39216, USA
5
Department of Orthopedics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
6
Otology and Neurotology Group CTS495, Department of Genomic Medicine, GENYO-Centre for Genomics and Oncological Research-Pfizer-University of Granada-Junta de Andalucia, PTS, 18016 Granada, Spain
7
Division of Otolaryngology, Department of Surgery, Instituto de Investigación Biosanitaria, ibs.GRANADA, Universidad de Granada, 18071 Granada, Spain
8
Musculoskeletal Research Center, Children’s Hospital Colorado, Aurora, CO 80045, USA
9
Meniere’s Disease Neuroscience Research Program, Faculty of Medicine & Health, School of Medical Sciences, The Kolling Institute, University of Sydney, Sydney, NSW 2006, Australia
10
Center for Children’s Surgery, Children’s Hospital Colorado, Aurora, CO 80045, USA
*
Author to whom correspondence should be addressed.
Genes 2023, 14(4), 831; https://doi.org/10.3390/genes14040831
Submission received: 8 March 2023 / Revised: 25 March 2023 / Accepted: 27 March 2023 / Published: 30 March 2023
(This article belongs to the Special Issue Feature Papers in Human Genomics and Genetic Diseases 2023)
Browse Figures
Review Reports Versions Notes

Abstract

:
Vertigo due to vestibular dysfunction is rare in children. The elucidation of its etiology will improve clinical management and the quality of life of patients. Genes for vestibular dysfunction were previously identified in patients with both hearing loss and vertigo. This study aimed to identify rare, coding variants in children with peripheral vertigo but no hearing loss, and in patients with potentially overlapping phenotypes, namely, Meniere’s disease or idiopathic scoliosis. Rare variants were selected from the exome sequence data of 5 American children with vertigo, 226 Spanish patients with Meniere’s disease, and 38 European–American probands with scoliosis. In children with vertigo, 17 variants were found in 15 genes involved in migraine, musculoskeletal phenotypes, and vestibular development. Three genes, OTOP1, HMX3, and LAMA2, have knockout mouse models for vestibular dysfunction. Moreover, HMX3 and LAMA2 were expressed in human vestibular tissues. Rare variants within ECM1, OTOP1, and OTOP2 were each identified in three adult patients with Meniere’s disease. Additionally, an OTOP1 variant was identified in 11 adolescents with lateral semicircular canal asymmetry, 10 of whom have scoliosis. We hypothesize that peripheral vestibular dysfunction in children may be due to multiple rare variants within genes that are involved in the inner ear structure, migraine, and musculoskeletal disease.

1. Introduction

Dizziness is a common symptom encountered in clinical practice, affecting approximately 20–30% of the population [1]. Illusionary states of dizziness or vertigo point to disorders of the vestibular system in the inner ear, and vestibular disorders are defined as a group of diseases leading to the transient or permanent loss of the vestibular function [2]. Pediatric vestibular diseases can be debilitating and inhibit children from participation in physical activities as well as affect their performance in school. The diagnosis and management of these diseases pose a challenge to clinicians due to variations in clinical presentation and overlaps in symptomatology among different disease states. Additionally, the interaction of the vestibular system with other organs of balance such as the neck and spine can further add to the complexity of managing vestibulopathy. For example, recent evidence from animal models and human clinical studies supported an association between vestibular disease and adolescent idiopathic scoliosis (AIS), such that the unilateral lesions of the otolithic and semicircular canal organs resulted in vertebral rotation and head tilt [3].
Despite the evidence of familial clustering in vestibular diseases, including Meniere’s disease [4] and vestibular migraine [5], studies on the genetic basis of vestibular diseases are few compared to those on sensorineural hearing loss. Genetic studies on possible candidate genes in vestibular diseases often involve those associated with syndromic and non-syndromic sensorineural hearing loss [2], with vestibular conditions initially not being considered as the primary symptoms. Because of the paucity of knowledge on the etiology of vestibular disorders, particularly in children, diagnoses are more frequently attributed to migraine rather than innate vestibulopathy [6]. Given the complex presentations of vertigo, we hypothesized that a combination of rare variants in a few genes, including candidate genes for inner ear disorders and migraine, may be present in each pediatric patient and contribute to the rarity and earlier onset of vestibular dysfunction in children, similar to what is observed in other pediatric immune or neurologic diseases [7,8]. With the availability of high-throughput massively parallel sequencing technology, we sought to identify genetic variants in pediatric patients with vestibular and balance disorders but not hearing loss or other syndromes.
To this end, this study aimed to identify rare, potentially deleterious coding variants using exome sequence data from patients with early onset non-syndromic vestibular dysfunction. From the exome sequence data, we identified rare variants in the genes involved in migraine, inner ear, and musculoskeletal conditions in American children with peripheral vestibulopathy and performed a network analysis for the identified genes. Due to the rarity of non-syndromic peripheral vertigo in children, we screened for rare or low-frequency variants in the same candidate genes using sequence data from two cohorts with potentially overlapping phenotypes: (1) familial and sporadic Meniere’s disease patients from Spain; and (2) European–American families with AIS, including children with asymmetry of the lateral semicircular canal of the inner ear as documented by MRI. Finally, we demonstrated the expression of two genes, namely, HMX3 and LAMA2, in human vestibular tissues.

2. Materials and Methods

2.1. Ethical Approvals and Subject Recruitment

All studies were performed according to the ethical principles as stated in the Declaration of Helsinki. Prior to the study’s initiation, this study was approved by the Colorado Multiple Institutional Review Board (protocols 06-1161, 07-0417, 09-0706, 17-1720, 19-1930, and 21-3246) and the Comite de Etica de Investigacion Clinica de Granada H2020-SC1-2019-848261. Informed consent was obtained from each family member who provided DNA samples and clinical data, including informed consent from the parents of children who participated in the study, and from each adult patient who provided vestibular tissue samples. Child assent was also documented as applicable.
Five patient cohorts were included in this study (Figure S1):
  • Cohort 1: For the pilot study, five children who were diagnosed with vestibular dysfunction and had a family history of vertigo were recruited into the study (Table 1). Patients were excluded if there was a diagnosis of hearing loss, known neurologic disorders, or other significant comorbidities. The five enrolled patients did not have any history of head trauma, notable past medical, prenatal, and neonatal events, and inner ear abnormalities seen by 2D high-resolution temporal bone CT or MRI. The results of audiometric testing and tympanometry were within the normal limits. Saliva samples were obtained from the study participants using Oragene saliva kits (DNA Genotek, Ottawa, ON, Canada). Genomic DNA was isolated from saliva using the manufacturer’s protocol.
Table
Table 1. Pediatric patients with peripheral vestibular disorders.
Table 1. Pediatric patients with peripheral vestibular disorders.
ID 1Age at Initial Consult SexEthnicityFamily History of MigraineDuration of SymptomsClinical Diagnosis
16 yearsFWhite non-HispanicNo2 yearsBenign paroxysmal vertigo of childhood
211 yearsMHispanicNo5 monthsVertigo
313 yearsFWhite non-HispanicYes9 yearsVestibular migraine
49 yearsFWhite non-HispanicYes6 yearsVestibular migraine
5 212 yearsFWhite non-HispanicYes8 yearsLeft-sided vestibular weakness
1 All five patients did not suffer from hearing loss, or family history of hearing loss or vertigo. 2 Patient 5 also has vitiligo. The four other patients did not have any known comorbidities.
  • Cohort 2: Meniere’s disease patients were recruited and diagnosed from different Spanish hospitals following the diagnostic criteria defined by the International Classification Committee for Vestibular Disorders of the Barany Society [9]. Other vestibular diseases were excluded after performing a complete audio-vestibular assessment, including MRI. The DNA from these patients were collected and extracted from blood or saliva using the QIAamp DNA Mini Kit (Qiagen, Venlo, the Netherlands) and Oragene saliva kits, respectively.
  • Cohort 3: European–American families with AIS were enrolled as previously described [10,11,12]. The families were selected for sequencing if the proband had no co-occurring congenital deformity or genetic disorder and was diagnosed with AIS based on a standing anteroposterior spinal radiograph showing ≥10° curvature by the Cobb method with pedicle rotation. In total, 3 to 4 AIS-affected individuals from each of the 28 families were selected for exome sequencing based on the scoliotic curve severity, the availability of DNA samples, and the genetic distance across the individuals [10,11].
  • Cohort 4: A second cohort of individuals with AIS (Table S1) were enrolled as above with added consent to obtain the morphological measurements of the semicircular canals using the three-dimensional reconstruction of images from T2-weighted MRI [13]. This previous study was performed to examine the association between the occurrence of semicircular canal defects and spine deformity. From cohort 4, eleven individuals with differences in angulation between the axial plane and the lateral semicircular canal when comparing the right and left inner ears (from here on referred to as LSCC asymmetry) were selected for Sanger sequencing of exons within two genes: HMX3 and OTOP1. Of note, out of eleven selected individuals with subtle changes in their inner ear structure, ten were previously diagnosed with AIS (Table S1), while the eleventh individual was designated as an AIS control due to normal spine curvature.
  • Cohort 5: Two American patients with vestibular schwannomas who underwent tumor resection via a translabyrinthine approach provided vestibular tissue samples that would otherwise be discarded during surgery. One patient self-identified as White/Caucasian, while the second patient refused to disclose their ethnicity. Both patients did not experience any preoperative symptoms of vertigo, suggesting normal vestibular function despite the ipsilateral nerve sheath tumor. Immediately upon removal, the vestibular tissue samples were placed in RNAlater (Invitrogen/Thermo Fisher, Waltham, MA, USA). The samples were stored at 4 °C and processed within 30 days.

2.2. Exome and Sanger Sequencing of DNA Samples

Exome sequencing was performed using DNA samples from the cohorts 1 to 3. The DNA samples from five American children with vestibular disorders {cohort 1} were submitted to the Northwest Genomics Center, University of Washington, for exome sequencing. The sequence capture was performed using the Twist Bioscience Human Core Exome Kit (South San Francisco, CA, USA) and an Illumina NovaSeq (San Diego, CA, USA). DNA samples from the Meniere’s disease cohort {cohort 2} were submitted for exome sequencing at 100× coverage using the Agilent SureSelect XT v6 Exome kit (Agilent Technologies, Santa Clara, CA, USA) and the Illumina NovaSeq 6000 platform. For the European–American family members with AIS {cohort 3}, DNA was extracted from the blood samples. Exome sequencing was completed using the Agilent SureSelect Human V5 (51 Mb) exon capture kit on an Illumina HiSeq 2500 at the Otogenetics Corporation (Atlanta, GA, USA), with a minimum average coverage of 50×. For all three cohorts, Burrows–Wheeler Aligner [14] was used to align the generated sequence data to the human reference sequence (hg19 for the US children with vestibular disease and the Spanish Meniere’s disease cohort, hg38 for the AIS cohort) and produce the .bam files. Variant calling was performed and the .vcf files were created using the Genome Analysis Toolkit [15].
For the validation of the candidate variants, Sanger sequencing was performed for rare variants that were selected from exome sequence data using the same five DNA samples from American children with vestibular dysfunction and available maternal DNA samples (Table 2). The list of genes that harbored these variants were then used to select rare predicted-to-be-damaging variants from the exome sequence data of individuals with Meniere’s disease or AIS. For the Meniere’s disease cohort, the variants identified in the probands were Sanger-sequenced in the rest of the DNA samples that were available from family members. In addition, exon 2 of HMX3 (NM_001105574.2) and exon 6 of OTOP1 (NM_177998.3) were Sanger-sequenced using eleven DNA samples from cohort 4 including 11 European–American probands with LSCC asymmetry, ten of whom had AIS.

2.3. Variant Prioritization and Gene Network Analysis

Exome sequence data from the five American children with vestibular dysfunction {cohort 1} were annotated using ANNOVAR (annovar.openbioinformatics.org, accessed on 8 March 2023) [16]. Variants were selected if they lie within genes known for: (a) hearing loss in humans (i.e., 150 syndromic and non-syndromic genes in a targeted genetic screening panel Otoscope v8 plus newly published genes); (b) mouse models with vestibular and/or hearing defects; (c) high expression in mouse vestibule based on the gene Expression Analysis Resource database (umgear.org, accessed on 8 March 2023); and (d) association with migraine (Table S2). The exome sequence data were also annotated using MutationTaster [17]; however, no potentially “disease-causing” indels were identified. In Colorado, the 10-year prevalence of pediatric vertigo without migraine (whether central or peripheral) was estimated at 2.5%, and for the rarer phenotype of co-occurring migraine and vertigo at 0.8% (unpublished data from the COMPASS database). Additionally, around half of the children who consulted at the same specialty clinic for vertigo were diagnosed with peripheral vestibular disease. Based on these estimates, single nucleotide variants were selected for further study if they have a: (a) minor allele frequency (MAF) < 0.001 in all populations in the Genome Aggregation Database (gnomAD v3.1.2, gnomad.broadinstitute.org, accessed on 8 March 2023), the Greater Middle East (GME) Variome database (igm.ecsd.edu/gme), Bravo (bravo.sph.umich.edu, TOPMed freeze 5), and All of Us (databrowser.researchallofus.org, accessed on 8 March 2023); (b) a scaled score ≥ 15 in the Combined Annotation-Dependent Depletion (CADD) database (cadd.gs.washington.edu, GRCh38-v1.6); and (c) prediction as damaging or deleterious by at least one bioinformatic tool in dbNSFP v4.1 (sites.google.com/site/jpopgen/dbNSFP). The bioinformatics tools in dbNSFP included FATHMM, fathmmMKL, a likelihood ratio test (LRT), M-CAP, metaLR, metaSVM, MutationTaster, PolyPhen2 HDIV/HVAR, PROVEAN, and SIFT (Table 2). Variants that satisfied these criteria were excluded if, based on the known literature from human and animal studies, the genes that harbored these variants were less likely to explain the patient’s presenting symptoms (Table S3).
Table
Table 2. Genetic variants identified in children with peripheral vestibular disorders.
Table 2. Genetic variants identified in children with peripheral vestibular disorders.
IDGeneRefSeq NM_#VariantHighest
MAF in
Databases 1		Damaging PredictionScaled CADD ScoreKnown Literature on Gene [References]MIM#
1TMEM130001134450c.52C>T (p.(Leu18Phe))0SI, MC24.1High expression in
developing mouse utricular hair cells [18]		n.a.
1LRP1 2002332c.13471G>C (p.(Asp4491His))(gA)OTH: 9.5 × 10–4ppHD, ppHV, LRT, MT24.8Associated with
migraine [19]		107770
1ECM1 2001202858c.1126T>C (p.(Cys376Arg))(AU)Lat:
9.9 × 10–5		SI, ppHD, ppHV, LRT, MT, FA, PR, mSVM, mLR, MC25.5Associated with
migraine [20,21]		602201
1CARF 2001352679c.1718C>T (p.(Ser573Phe))(AU)OTH: 1.1 × 10–4SI, ppHD, ppHV, MT27.9Associated with
migraine [20,22]		607586
2CTIF014772c.1547A>G (p.(Gln516Arg))(AU)Eur: 3.95 × 10–4LRT, fMKL20.3Associated with
migraine [19]		613178
2KIF6001289024c.1838G>A (p.(Arg613Gln))(AU)Eur:
7.3 × 10–5		ppHD, MT, fMKL23.6High expression in
developing mouse utricular hair cells [18]		613919
2KLC2 2001134774c.976C>T (p.(Gln326*))0LRT, fMKL38.0Knockdown in zebrafish resulted in twisted tail and inability to swim [23]611729
2OTOP2178160c.379A>G (p.(Ser127Gly))(gA)NFE: 1.5 × 10–5MT, fMKL22.0Maps to a candidate
region of USH1G [24]		607827
3HMX3001105574c.534G>T (p.(Glu178Asp))Bravo:
1.6 × 10–5		ppHD, LRT, MT, FA, mLR, MC17.8KO mice exhibit abnormal circling behavior and vestibular defects [25]613380
3LRP1002332c.13169A>C (p.(Asp4390Thr))0fMKL22.0Associated with
migraine [19]		107770
4MYO5A 2000259c.3257G>A (p.(Ser1086Asn))0LRT, fMKL20.6Associated with Elejalde syndrome; involved in neurologic development [26]276903
4MYO5A 2000259c.343C>A (p.(Gln115Lys))0SI, LRT, MT, FA, mLR, MC, fMKL23.5
4RNF213001256071c.9197C>T (p.(Pro3066Leu))(AU)Eur:
4.2 × 10–5		SI, LRT, MT, PR, fMKL25.3Associated with
migraine [22]		613768
4APOE000041c.875G>T (p.(Arg292Leu))(AU)Eur:
2.1 × 10–5		SI, ppHD, ppHV, PR, MC, fMKL31.0Associated with
migraine [27,28]		107741
5LAMA2 2000426c.6229G>A (p.(Ala2077Thr))(gA)NFE: 4.6 × 10–4MT, fMKL16.9Abnormal cochlear and vestibular morphology in homozygous dy/dy mice [29]156225
5SLC35D2007001c.601A>G (p.(Lys201Glu))(gA)NFE: 1.5 × 10–5SI, LRT, MT, PR, MC, fMKL29.1Associated with
migraine [19]		609182
5OTOP1177998c.164A>G (p.(Gln55Arg))(AU)Eur: 1.98 × 10–4MT, MC17.3Associated with non-syndromic vestibular disorder with otoconial agenesis in mice [30]607806
1 Highest MAF in gnomAD, GME, Bravo, or All of Us. 2 Present in maternal DNA. Abbreviations: (AU): All of Us database; CADD: Combined Annotation-Dependent Depletion; Eur: European; FA: FATHMM; fMKL: fathmmMKL; (gA): gnomAD/Genome Aggregation Database; KO: knockout; Lat: Latin American; LRT: likelihood ratio test; MAF: minor allele frequency; MC: M-CAP; mLR: metaLR; mSVM: MetaSVM; MT: MutationTaster; n.a., not available; NFE: non-Finnish European; OTH: other; ppHD: PolyPhen2 HDIV; ppHV: PolyPhen2 HVAR; PR: PROVEAN; SI: SIFT.
The Variant Effect Predictor was used to annotate the Meniere’s disease dataset from cohort 2 [31]. Variants were selected if they were found within the genes identified in American children with vestibular disease, and if they are rare and predicted to be damaging based on the criteria outlined above.
For cohort 3 with AIS, variants were identified from the exome sequence data using FreeBayes then filtered using SnpEff version 4.1 [32]. Custom scripts were used to select non-synonymous, coding indel, and splice variants with MAF ≤ 0.05, which lie within the genes listed in Table 2. Single nucleotide variants were further selected if deemed damaging by at least one prediction tool in dbNSFP v3.0.
Network analysis was performed using NetworkAnalyst (networkanalyst.ca, accessed 25 March 2023) [33] and the InnateDB [34] database was used to identify protein–protein interactions for genes identified to have variants among the children with peripheral vestibular dysfunction. Enrichment analysis was performed using the PANTHER, Gene Ontology, and REACTOME databases within the NetworkAnalyst website, while noting significant pathways using the false discovery rate (FDR)-adjusted-p < 0.05.

2.4. RNA Isolation and RT-PCR for Human Vestibular Tissues

RNA was isolated from human vestibular tissues using the RNeasy Micro Kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocol, with the addition of a pre-homogenization step using glass beads (2 mm and 3 mm) and the MO BIO Vortex Adapter (Carlsbad, CA, USA). The SuperScript IV First-Strand Synthesis System with ezDNase Enzyme (Thermo Fisher Scientific, Waltham, MA, USA) was used for cDNA synthesis. For two genes, HMX3 and LAMA2, RT-PCR was performed using the DreamTaq Green PCR Master Mix (Thermo Fisher) with an annealing temperature of 60 °C and 35 cycles. PCR products were run on a 4% agarose gel and the Universal Human Reference RNA (Invitrogen/Thermo Fisher) was used as the positive control.

3. Results

3.1. Rare Genetic Variants in Pediatric Patients with Early Onset Vestibular Dysfunction

Variants were initially identified from the exome sequence data of five children with vestibular dysfunction (cohort 1, Table 1). Seventeen rare coding heterozygous variants, predicted to be deleterious, were identified (Table 2). All fifteen genes have a moderate-to-high expression in developing mouse vestibules (umgear.org, accessed on 8 March 2023). Seven out of the seventeen rare variants were found in genes which were previously associated with migraine in genome-wide or candidate gene association studies [19,20,22,27,28] that used common variant data from adult patients (Table 2). A description of each patient’s clinical profile in light of the identified rare variants is hereby presented.
  • Patient 1: For two years prior to consult, a six-year-old female experienced intermittent vertigo lasting 15–60 min, occurring 2–3 times per month, and without associated tinnitus, hearing loss, headaches, and visual changes. She had abnormal bilateral findings with the head impulse test and was diagnosed with benign paroxysmal vertigo of childhood (BPVC). Exome sequencing revealed that she had three rare variants in migraine genes, LRP1 c.13471G>C (p.(Asp4491His)), ECM1 c.1126T>C (p.(Cys376Arg)), and CARF c.1718C>T (p.(Ser573Phe)) [19,20,21,22]. At the time of consult, patient 1 did not exhibit migraine symptoms; however, BPVC is considered a migraine precursor [35]. An additional variant in a gene highly expressed in developing mouse utricular hair cell [18], TMEM130 c.52C>T (p.(Leu18Phe)), was also found.
  • Patient 2: An 11-year-old male reported multiple episodes of vertigo lasting minutes to hours during the last five months prior to consultation. He did not have tinnitus, hearing loss, or headaches. His head impulse test had abnormal findings bilaterally, and caloric testing revealed a 21% reduced response on the right side. Rare variants were noted in genes previously associated with neurodevelopmental disorders [23,36]: KIF6 c.1838G>A (p.(Arg613Gln)) [36] and KLC2 c.976C>T (p.(Gln326*)). In addition, he had a rare variant in another migraine-associated gene, CTIF c.1547A>G (p.(Gln516Arg)) [19]. A fourth rare variant, c.379A>G (p.(Ser127Gly)), was found within OTOP2, a gene which maps to the candidate region of Usher syndrome 1G (USH1G) [24], which includes congenital hearing loss, vestibular areflexia, and adolescent-onset retinitis pigmentosa. Note that patient 2 does not have Usher syndrome, hearing loss, or eye disease.
  • Patient 3: A 13-year-old female presented with on-and-off vertigo in the previous nine years and episodes of migraine headaches separate from the vertigo attacks. The clinical evaluation revealed an abnormal right-sided head impulse test. Based on her presentation, she was diagnosed with probable vestibular migraine. A damaging variant in the homeobox family protein HMX3 c.534G>T (p.(Glu178Asp)) was identified from her exome sequence data. The knockout of HMX3 in mice led to abnormal circling behavior and severe structural defects in the inner ear vestibule [25]; however, prior to this work, there was no strong evidence of vertigo-causal HMX3 variants in humans [37]. In addition, a rare variant, c.13169A>C (p.(Asn4390Thr)), was identified within the migraine-associated gene LRP1 and was deemed pathogenic by the bioinformatic predictor fathmmMKL.
  • Patient 4: A nine-year-old female had recurrent, severe headaches which were unresponsive to a drug cocktail containing Naproxen, Prochlorperazine, and Diphenhydramine. Her headaches were associated with photophobia, phonophobia, vertigo, nausea, vomiting, and occasional tinnitus. The clinical evaluation revealed bilateral torsional and rotational gaze nystagmus, and an abnormal head impulse test on the right. Based on her presentation, she was diagnosed with vestibular migraine. She has novel rare variants in two migraine-associated genes [22,27,28,38]: APOE c.875G>T (p.(Arg292Leu)) [26,33] and RNF213 c.9197C>T (p.(Pro3066Leu)). Additionally, two variants within MYO5A c.3257G>A (p.(Ser1086Asn)) and c.343C>A (p.(Gln115Lys)), a gene previously implicated in neurodevelopment [26], were identified from her exome sequence data. The Sanger sequencing of maternal DNA revealed that these two MYO5A variants were inherited in cis.
  • Patient 5: A 12-year-old female presented with an 8-year history of episodic vertigo, lasting minutes to hours, and occasionally occurring when performing gymnastics. The clinical evaluation revealed a bilaterally abnormal head impulse test and 50% left canal paresis on caloric testing. She was diagnosed with left-sided vestibular weakness. A rare missense variant c.6229G>A (p.(Ala2077Thr)) was identified in LAMA2, which is known for merosin-deficient congenital muscular dystrophy 1A (MDC1A; MIM 607855) [29]. Furthermore, Lama2-knockout mice demonstrated cochlear and vestibular malformations [29]. Additionally, two rare variants—c.601A>G (p.(Lys201Glu)) in the migraine-associated gene SLC35D2 [19] and c.164A>G (p.(Gln55Arg)) within OTOP1—were identified in the exome data of patient 5. The knockout of Otop1 previously resulted in non-syndromic vestibular defects and otoconial agenesis in mice [30].

3.2. Network Analysis

Network analysis was performed using as an input the 15 genes which harbored rare variants. The resulting subnetwork (Figure 1) included 9 genes: migraine-associated genes APOE, LRP1, CARF, CTIF, RNF213, and ECM1; LAMA2, which is associated with vestibular anomalies in mice; and the neurodevelopment-associated genes MYO5A and KLC2. Function analysis of this subnetwork revealed 23 significant PANTHER BP pathways, 120 GO BP pathways, and 98 REACTOME pathways. The top pathways from each analysis are listed in Table 3. The pathways common among these databases involved: membrane transport (i.e., membrane trafficking, vesicle mediated transport, exocytosis, receptor mediated endocytosis); the regulation of apoptosis (i.e., activation of BH3-only proteins, intrinsic pathway for apoptosis, activation of BAD to mitochondria, negative regulation of apoptotic processes); coagulation or hemostasis (i.e., hemostasis, blood coagulation, platelet activation, signaling and aggregation, platelet degranulation); and protein localization (i.e., translocation of GLUT4 to plasma membrane, protein localization, protein targeting). The pathways involved with membrane transport included four genes in the subnetwork, i.e., APOE, LRP1, KLC2, and MYO5A.

3.3. Rare Genetic Variants in Spanish Patients with Meniere’s Disease

A total of 226 patients with familial or sporadic Meniere’s disease {cohort 2} were screened for novel or rare variants in the 15 candidate genes identified in children with vestibular dysfunction (Table 2 and Table 4). Three genes, ECM1, OTOP1, and OTOP2, harbored rare variants in Spanish patients with Meniere’s disease. A rare ECM1 variant c.844C>T (p.(Arg282Trp)) was identified in patient SANT19 who had familial Meniere’s disease but no migraine symptoms at the time of diagnosis. This variant was likewise identified in her father, who also suffered from Meniere’s disease. Additionally, a rare variant, OTOP1 c.380A>T (p.(His127Leu)), was found in a sporadic patient suffering from bilateral Meniere’s disease since the age of 42. Within OTOP2, the c.760G>A (p.(Ala254Thr)) variant was identified in a sporadic patient with Meniere’s disease since early adulthood. Overall, these findings in the adult patients with Meniere’s disease in cohort 2 demonstrate that rare coding variants were identified in the same three genes as in the children with vertigo from cohort 1.

3.4. Genetic Variants in European–American Probands with AIS and LSCC Asymmetry

In the AIS cohorts {cohorts 3–4}, no variants in HMX3 were identified in exome sequence data from cohort 3, which includes 28 families with AIS, or by Sanger sequencing of HMX3 exon 2 in cohort 4 that has 11 children with LSCC asymmetry. From cohort 3, 3-4 AIS-affected individuals from each of the 2 families with ID 8 and 81 had the same variant OTOP1 c.310C>A (p.(Leu104Met)). This variant had a MAF of 5% in GME Israel and 1% in gnomAD Finnish, a scaled CADD score of 23.9, and was predicted to be damaging by PolyPhen2 HDIV, MutationTaster, M-CAP, and fathmm-MKL_coding. While family 81 has isolated AIS with varying curvatures of the spine, family 8 has a known pathogenic FBN1 variant c.7754T>C (p.Ile2585Thr) co-segregating with the AIS phenotype as well as cardiac phenotypes within the family. This latter finding makes a potential association between the OTOP1 c.310C>A variant and AIS less likely.
On the other hand, a rare deleterious OTOP1 c.29C>G (p.(Ser10Trp)) variant was identified in 11 adolescent individuals (cohort 4; Table S4, Figure S2), all of whom had LSCC asymmetry by MRI, but only 10 of whom had AIS [13]. This rare OTOP1 c.29C>G variant has a scaled CADD score of 14.98 and was deemed deleterious by SIFT. The identification of the OTOP1 c.29C>G variant in 11 individuals with LSCC asymmetry, 1 of whom did not have AIS, strengthens a potential association between OTOP1 and subtle vestibular defects.

3.5. HMX3 and LAMA2 Expression in Human Vestibular Tissues

Vestibular tissues, including the normal utricle, saccule, and semicircular canal ampullae from two patients with left-sided vestibular schwannoma {cohort 5}, were collected for the gene expression analysis. The first sample was taken from a 63-year-old female with ipsilateral moderate-to-profound sensorineural hearing loss and a feeling of disequilibrium without vertigo. The second sample was taken from a 60-year-old female with moderate-to-severe ipsilateral hearing loss without dizziness, imbalance, or vertigo. RT-PCR revealed that HMX3 and LAMA2 were strongly expressed in the collected human vestibular tissues (Figure 2).
In the gEAR database, 12 out of 15 genes in Table 2, including HMX3 and LAMA2, were detected in bulk RNA-seq data from adult human vestibular sensory epithelia (Forge 2020 dataset). On the other hand, three genes, CTIF, OTOP1, and OTOP2, were not found in this human dataset from gEAR. It should be noted that in single-cell RNA-seq data from mice, homologs for all 15 genes were detected in: macrophages, hair cells, and neuronal cells of the crista ampullaris (Bermingham–Donough 2021 dataset); and Atoh1-induced utricular supporting cells (Groves 2019 dataset). In particular, Otop1 was previously known to be expressed in macular epithelial cells and the overlying gelatinous membrane within the mouse vestibule [30].

4. Discussion

In total, 17 rare variants within 15 novel candidate genes were identified in 5 children with peripheral vestibular dysfunction (Table 1 and Table 2). Multiple rare variants were noted per child, with varied clinical presentations for each patient. These findings suggest that non-syndromic vertigo may be due to multiple rare variants contributing to early onset vertigo, which is rare in children. Of the candidate genes, rare variants were identified in HMX3, LAMA2, and OTOP1, which were shown in mouse models to be strong candidate genes for vestibular dysfunction. Additionally, we demonstrated that HMX3 and LAMA2 are highly expressed in human vestibular tissues (Figure 2). Rare variants in OTOP1, OTOP2, and ECM1 were also identified in Spanish probands and families with adult-onset Meniere’s disease, although in each of these Spanish families, only one variant from our candidate genes was identified (Table 4). Furthermore, a network analysis revealed that migraine genes CTIF, APOE, LRP1, RNF213, CARF, and ECM1, musculoskeletal genes KLC2 and MYO5A, as well as LAMA2 were connected to a gene subnetwork, and some of these genes play a role in significant pathways for membrane transport, protein targeting, and coagulation (Figure 1, Table 3). Taken together, our findings support the hypothesis that multiple rare variants in the genes involved in the inner ear structure, migraine, and musculoskeletal development contribute to the early development of peripheral balance disorders.
Among the notable candidate genes are OTOP1, HMX3, and LAMA2. These genes were previously shown to cause vestibular dysfunction as observable behavioral changes as well as structural abnormalities in the inner ears of knockout mice [25,29,30]. OTOP1 encodes an ion channel that is involved in maintaining the ionic environment during otoconia formation [30,39]. The mouse mutants tilted (tlt) and mergulhador (mlh) harbor single missense variants p.Ala151Glu and p.Leu408Gln within Otop1 that led to an impaired balance and otoconial agenesis [30]. Histologically, the total absence of otoconia in the utricle or saccule or, more occasionally, few giant otoconia in the saccule were observed in Otop1-mutant mice [30]. However, the involvement of these genes in human vestibular dysfunction is less studied. Recently a common variant rs2272744 upstream of OTOP1 was associated with vertigo in adult individuals of European descent in a genome-wide meta-analysis [40]. In our cohort 1, patient 5, who has a rare OTOP1 missense variant (Table 2), reported vertigo symptoms during gymnastic maneuvers, suggesting possible otolith dysfunction in the semicircular canals. Additionally, a male Spanish patient with the onset of symptoms of Meniere’s disease at 42 years old and a maternal family history of vertigo and deafness also had a rare OTOP1 missense variant (Table 4). Last, an OTOP1 c.29C>G (p.(Ser10Trp)) variant was identified in 11 adolescents with LSCC asymmetry (Figure S2), only 10 of whom had AIS [13]. AIS is a common adolescent spinal deformity of unknown etiology; however, various studies have suggested abnormal somatosensory and vestibular integration as possible mechanisms that result in altered posture and balance [41,42]. Overall, these findings indicate that OTOP1 is a strong candidate gene for non-syndromic vestibular dysfunction in humans.
Two other genes, HMX3 and LAMA2, were identified to have rare missense variants in children with vertigo and are strongly expressed in human vestibular tissues (Figure 2). Additionally, mouse models strongly suggest these as candidate genes for vestibular dysfunction. Hmx3-knockout mice demonstrated vestibular defects as abnormal circling behavior and structural malformations in the form of utricle and saccule fusion with a significant reduction in sensory epithelia and the absence of the horizontal semicircular canal crista [25]. Although less well-described, human studies also suggest HMX3 involvement in vertigo. A hemizygous deletion in chromosome 10 was previously described in four patients with vestibular impairment, congenital hearing loss, and inner ear abnormalities (e.g., enlarged, abnormally shaped vestibule with absent horizontal and posterior semicircular canals) [43]. This deleted 10q region contained 20 genes, including HMX3 and HMX2. In another previous study, a synonymous variant HMX3 c.114C>T was identified in two patients with superior semicircular canal dehiscence; however, no additional evidence was presented to show that this synonymous variant is potentially functional [37]. The rare deleterious missense HMX3 variant c.534G>T (p.(Glu178Asp)) that was identified in patient 3 (Table 2) further lends support to HMX3 as another strong candidate gene for non-syndromic vestibulopathy in humans.
LAMA2 encodes for the alpha-2 subunit of laminin-2, is highly expressed in the brain and Schwann cells, and plays a role in neuronal migration [44]. LAMA2 variants are associated with congenital muscular dystrophy type 1A (MDC1A), a condition characterized by severe motor weakness within the first six months of life [45]. One patient with MDC1A was reported to exhibit severe panic disorders and vertigo triggered by watching moving stimuli and rapid head movement [46]. The mouse model for human congenital muscular dystrophy (C57BL/6J-Lama2dy) had increased ABR thresholds and abnormal cochlear and vestibular structural malformations, in addition to muscular deficits in the homozygous (dy/dy) state [29]. These vestibular structural malformations included fibrous deposition throughout the membranous labyrinth and degeneration of the sensory structures in the semicircular crista and saccular macula. Patient 5 did not present with headaches, muscular weakness, or hearing loss and had normal inner ear structures on imaging. She did have a family history of migraine and right-sided non-syndromic vestibular weakness. It should be noted that patient 5 had variants in one migraine gene, SLC35D2, and two inner ear genes, OTOP1 and LAMA2.
The majority of the identified variants were found in genes previously associated with migraine (LRP1, ECM1, CARF, CTIF, RNF213, APOE, SLC35D2), with two different rare LRP1 variants each identified in two unrelated children with vertigo. This finding supports the hypothesis that migraine and vertigo may share some common genetic pathways. About a quarter of migraineurs report vertigo episodes either co-occurring with their headache or as separate episodes [47]. Moreover, about 30–50% of adult patients with vertigo complain of migraines [48]. Previous attempts at determining key genes in migraine-associated vertigo suggest the involvement of ion channel genes, such as CACNA1A, ATP1A2, and SCN1A [49]. In this study, we identified rare damaging variants in OTOP1 and OTOP2 which encode proton-selective ion channels (Table 2 and Table S3). Other than these, network analyses revealed vesicular transport, membrane trafficking, coagulation or hemostasis, and the regulation of apoptosis as the most significant pathways (Figure 1, Table 3). Some of these pathways make sense in light of previous studies; for example, thrombophilic conditions were previously described in patients with migraine [50,51] and acute unilateral vestibular paresis [52]. Additionally, in an exome sequencing study of early onset Meniere’s disease patients, network analysis revealed the genes involved in cell death, with the apoptosis of hair cells being suggested as a potential pathologic mechanism [53]. However, familial Meniere’s disease is a polygenic disorder with different inheritance models, including autosomal dominant [54], autosomal recessive or compound heterozygous [55], and digenic inheritance [56]. Therefore, although there seems to be some overlap in the genes and pathways involved in pediatric vertigo, migraine, and Meniere’s disease, the observation that the children with non-syndromic vertigo have multiple rare coding variants in several genes involved in different phenotypes or pathways might indicate that the unique clinical presentation of each child with vertigo is due to the ultra-rare combination of coding variants identified in each patient.
Certain limitations of this study must be considered. First, there is difficulty in assessing vertigo from different forms of dizziness, particularly in the pediatric population. Even with the aid of advanced computer algorithms but without genetic data, diagnostic accuracy in the assessment of the dizzy patient is estimated at around 65% [57]. Second, this study used a list of candidate genes based on known inner-ear-expressed genes, genes previously associated with balance disorders in mice, and migraine genes. Other potentially novel genes may be involved with vestibulopathy in our patients; however, our approach was limited due to our sample size. Third, the variants identified in this study should be further assessed for their functional effects using variant-specific in vitro or animal model studies. However, such functional studies focusing on single genes or variants will not be able to fully replicate the effects of multiple (≥2) rare variants per patient. The ultra-rare combinations of variants that result in unique clinical presentations per patient also make it difficult to replicate findings in other probands or families. For example, through the Undiagnosed Diseases Network (UDN), we attempted to identify additional patients with undiagnosed rare diseases and also rare variants in the same candidate genes reported here but did not identify patients with a strong overlap in phenotypes, due in part to the lack of detailed audiovestibular examinations in UDN patients. Finally, only rare (MAF ≤ 0.001) coding variants were included in this study and we were not able to explore non-coding or structural variants. It is possible that the combination of rare and common variants may be responsible for vestibulopathies in pediatric patients, but studying interactions between rare and common variants for vertigo will require large-scale association studies using whole-genome data. Due to these limitations that affect the current state of genomic sciences overall, we thought it would be important to publish these candidate genes in order to facilitate rare variant identification and the genetic diagnosis of other patients with similar phenotypes and variants in the same genes. Our hope is that, eventually, the sequencing of rare variants will be useful to tailor the diagnosis and management of individuals with vestibular disorders.

5. Conclusions

In summary, novel and rare missense variants were identified in unrelated children with early onset vestibular dysfunction, which were supported by: the identification of additional rare variants in older patients with Meniere’s disease or LSCC asymmetry with AIS; a strong expression in mouse and human vestibular tissues; and/or previously published mouse models with vestibular deficits and structural anomalies of the vestibular apparatus. Multiple rare variants were found in each patient, suggesting that earlier vestibular dysfunction may be due to the combined effects of rare coding variants in different genes. Among the variant-containing genes, OTOP1, HMX3, and LAMA2 are strong candidates for vestibulopathy as the mouse models for these genes demonstrated both behavioral and structural abnormalities. The follow-up of patients is recommended, particularly for children with rare damaging variants in migraine-associated genes but currently without migraine symptoms. In the future, a better understanding of the genetic basis of peripheral vestibular diseases will lead to improved diagnostics through genetic screening and tailored patient care.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/genes14040831/s1; Figure S1: Study flowchart; Figure S2: OTOP1 c.29C>G (p.(Ser10Trp)) variant identified in 11 patients with LSCC asymmetry, 10 of whom had AIS; Table S1: AIS patients with LSCC asymmetry; Table S2: List of genes used for selecting rare variants from exome sequence data; Table S3: Excluded rare variants that were identified in exome sequence data of five US children with vestibular dysfunction; Table S4: OTOP1 exon 6 variants on hg19 chromosome 4 that were identified in US adolescents with LSCC asymmetry.

Author Contributions

Conceptualization, M.A.S., O.A.K., S.P.G., N.H.-M., J.A.L.-E. and R.L.P.S.-C.; methodology, M.A.S., O.A.K., S.P.G., N.H.-M., J.A.L.-E. and R.L.P.S.-C.; validation, A.A.M.S., L.F., E.A.T., C.I.W., P.M.C., P.R.-N., N.H.-M., J.A.L.-E. and R.L.P.S.-C.; formal analysis, A.A.M.S. and P.M.C.; investigation, A.A.M.S., M.A.S., O.A.K., L.F., E.A.T., P.M.C. and P.R.-N.; resources, M.A.S., S.P.G., N.H.-M., J.A.L.-E. and R.L.P.S.-C.; data curation, A.A.M.S., M.A.S., E.A.T., C.I.W., L.F., P.R.-N., N.H.-M. and R.L.P.S.-C.; writing—original draft preparation, A.A.M.S., O.A.K., N.H.-M., J.A.L.-E. and R.L.P.S.-C.; writing—review and editing, A.A.M.S., O.A.K., N.H.-M., J.A.L.-E. and R.L.P.S.-C.; supervision, M.A.S., S.P.G., N.H.-M., J.A.L.-E. and R.L.P.S.-C.; project administration, A.A.M.S., M.A.S., O.A.K., E.A.T., N.H.-M., J.A.L.-E. and R.L.P.S.-C.; funding acquisition, S.P.G., N.H.-M., J.A.L.-E. and R.L.P.S.-C. All authors have read and agreed to the published version of the manuscript.

Funding

A.A.M.S. received a scholarship from the Philippine Council for Health and Research Development of the Department of Science and Technology (PCHRD-DOST) under the Research Enrichment (Sandwich) Grant of the Accelerated Science and Technology Human Resource Development Program. O.A.K. was supported by the US National Institutes of Health (NIH)—National Institute on Deafness and Other Communication Disorders (NIDCD) grant T32 DC012280 (to Sue C. Kinnamon and Herman A. Jenkins). This work was supported by the NIH through the NIDCD grants R01 DC019642 (to R.L.P.S.-C. and Ivana V. Yang) and R01 DC013912 (to S.P.G.); and the National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R01 AR068292 (to N.H.-M.). Funding was also provided by Junta de Andalucia, grant Retos en Investigacion PY20_00303 (to J.A.L.-E.).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Colorado Multiple Institutional Review Board (protocols 06-1161, 07-0417, 09-0706, 17-1720, 19-1930 and 21-3246) and the Comite de Etica de Investigacion Clinica de Granada H2020-SC1-2019-848261.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Variant information is being deposited to the ClinVar database.

Acknowledgments

We thank all the patients and families who provided clinical data and samples for this study. We also thank TC Bootpetch for PCR-Sanger sequencing work, S Lalani and JA Mokry from the Undiagnosed Diseases Network, and SD Hirsch and the Health Data Compass (healthdatacompass.org, accessed on 8 March 2023) for prevalence data.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Yardley, L.; Owen, N.; Nazareth, I.; Luxon, L. Prevalence and presentation of dizziness in a general practice community sample of working age people. Br. J. Gen. Pract. 1998, 48, 1131–1135. [Google Scholar] [PubMed]
  2. Frejo, L.; Giegling, I.; Teggi, R.; Lopez-Escamez, J.A.; Rujescu, D. Genetics of vestibular disorders: Pathophysiological insights. J. Neurol. 2016, 263 (Suppl. 1), S45–S53. [Google Scholar] [PubMed]
  3. Hawasli, A.H.; Hullar, T.E.; Dorward, I.G. Idiopathic scoliosis and the vestibular system. Eur. Spine J. 2015, 24, 227–233. [Google Scholar]
  4. Requena, T.; Espinosa-Sanchez, J.M.; Cabrera, S.; Trinidad, G.; Soto-Varela, A.; Santos-Perez, S.; Teggi, R.; Perez, P.; Batuecas-Caletrio, A.; Fraile, J.; et al. Familial clustering and genetic heterogeneity in Meniere’s disease. Clin. Genet. 2014, 85, 245–252. [Google Scholar] [PubMed]
  5. Paz-Tamayo, A.; Perez-Carpena, P.; Lopez-Escamez, J.A. Systematic review of prevalence studies and familial aggregation in vestibular migraine. Front. Genet. 2020, 11, 954. [Google Scholar]
  6. Fancello, V.; Palma, S.; Monzani, D.; Pelucchi, S.; Genovese, E.; Ciorba, A. Vertigo and dizziness in children: An update. Children 2021, 8, 1025. [Google Scholar]
  7. Richter, G.M.; Wagner, G.; Reichenmiller, K.; Staufenbiel, I.; Martins, O.; Löscher, B.S.; Holtgrewe, M.; Jepsen, S.; Dommisch, H.; Schaefer, A.S. Exome Sequencing of 5 Families with Severe Early-Onset Periodontitis. J. Dent. Res. 2022, 101, 151–157. [Google Scholar]
  8. Krenn, M.; Wagner, M.; Hotzy, C.; Graf, E.; Weber, S.; Brunet, T.; Lorenz-Depiereux, B.; Kasprian, G.; Aull-Watschinger, S.; Pataraia, E.; et al. Diagnostic exome sequencing in non-acquired focal epilepsies highlights a major role of GATOR1 complex genes. J. Med. Genet. 2020, 57, 624–633. [Google Scholar]
  9. Lopez-Escamez, J.A.; Carey, J.; Chung, W.H.; Goebel, J.A.; Magnusson, M.; Mandalà, M.; Newman-Toker, D.E.; Strupp, M.; Suzuki, M.; Trabalzini, F.; et al. Diagnostic criteria for Menière’s disease. J. Vestib. Res. 2015, 25, 1–7. [Google Scholar]
  10. Baschal, E.E.; Wethey, C.I.; Swindle, K.; Baschal, R.M.; Gowan, K.; Tang, N.L.S.; Alvarado, D.M.; Haller, G.E.; Dobbs, M.B.; Taylor, M.R.G.; et al. Exome sequencing identifies a rare HSPG2 variant associated with familial idiopathic scoliosis. G3 (Bethesda) 2014, 5, 167–174. [Google Scholar]
  11. Baschal, E.E.; Terhune, E.A.; Wethey, C.I.; Baschal, R.M.; Robinson, K.D.; Cuevas, M.T.; Pradhan, S.; Sutphin, B.S.; Taylor, M.R.G.; Gowan, K.; et al. Idiopathic scoliosis families highlight actin-based and microtubule-based cellular projections and extracellular matrix in disease etiology. G3 (Bethesda) 2018, 8, 2663–2672. [Google Scholar]
  12. Terhune, E.A.; Wethey, C.I.; Cuevas, M.T.; Monley, A.M.; Baschal, E.E.; Bland, M.R.; Baschal, R.; Trahan, G.D.; Taylor, M.R.G.; Jones, K.L.; et al. Whole exome sequencing of 23 multigeneration idiopathic scoliosis families reveals enrichments in cytoskeletal variants, suggests highly polygenic disease. Genes 2021, 12, 922. [Google Scholar] [PubMed]
  13. Carry, P.M.; Duke, V.R.; Brazell, C.J.; Stence, N.; Scholes, M.; Rousie, D.L.; Miller, N.H. Lateral semi-circular canal asymmetry in females with idiopathic scoliosis. PLoS ONE 2020, 15, e0232417. [Google Scholar]
  14. Li, H.; Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25, 1754–1760. [Google Scholar]
  15. McKenna, A.; Hanna, M.; Banks, E.; Sivachenko, A.; Cibulskis, K.; Kernystsky, A.; Garimella, K.; Altshuler, D.; Gabriel, S.; Daly, M.; et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010, 20, 1297–1303. [Google Scholar]
  16. Wang, K.; Li, M.; Hakonarson, H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010, 38, e164. [Google Scholar]
  17. Schwarz, J.M.; Cooper, D.N.; Schuelke, M.; Seelow, D. MutationTaster2: Mutation prediction for the deep-sequencing age. Nat. Methods 2014, 11, 361–362. [Google Scholar]
  18. Scheffer, D.I.; Shen, J.; Corey, D.P.; Chen, Z.Y. Gene expression by mouse inner ear hair cells during development. J. Neurosci. 2015, 35, 6366–6380. [Google Scholar]
  19. Anttila, V.; Winsvold, B.S.; Gormley, P.; Kurth, T.; Bettella, F.; McMahon, G.; Kallela, M.; Malik, R.; de Vries, B.; Terwindt, G.; et al. Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat. Genet. 2013, 45, 912–917. [Google Scholar]
  20. van den Maagdenberg, A.M.J.M.; Nyholt, D.R.; Anttila, V. Novel hypotheses emerging from GWAS in migraine? J. Headache Pain 2019, 20, 5. [Google Scholar]
  21. Claeys, K.G.; Claes, L.R.F.; Van Goethem, J.W.M.; Sercu, S.; Merregaert, J.; Lambert, J.; Van Marck, E.A.; Parizel, P.M.; De Jonghe, P. Epilepsy and migraine in a patient with Urbach-Wiethe disease. Seizure 2007, 1, 465–468. [Google Scholar]
  22. Gormley, P.; Anttila, V.; Winsvold, B.S.; Palta, P.; Esko, T.; Pers, T.H.; Farh, K.H.; Cuenca-Leon, E.; Muona, M.; Furlotte, N.A.; et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat. Genet. 2016, 48, 856–866. [Google Scholar]
  23. Melo, U.S.; Macedo-Souza, L.I.; Figueiredo, T.; Muotri, A.R.; Gleeson, J.G.; Coux, G.; Armas, P.; Calcaterra, N.B.; Kitajima, J.P.; Amorim, S.; et al. Overexpression of KLC2 due to a homozygous deletion in the non-coding region causes SPOAN syndrome. Hum. Mol. Genet. 2015, 24, 6877–6885. [Google Scholar]
  24. Hurle, B.; Marques-Bonet, T.; Antonacci, F.; Hughes, I.; Ryan, J.F.; NISC Comparative Sequencing Program; Eichler, E.E.; Ornitz, D.M.; Green, E.D. Lineage-specific evolution of the vertebrate Otopetrin family revealed by comparative genomic analyses. BMC Evol. Biol. 2011, 11, 23. [Google Scholar]
  25. Wang, W.; Van De Water, T.; Lufkin, T. Inner ear and maternal reproductive defects in mice lacking the Hmx3 homeobox gene. Development 1998, 634, 621–634. [Google Scholar]
  26. Bahadoran, P.; Ortonne, J.P.; Ballotti, R.; de Saint-Basile, G. Comment on Elejalde syndrome and relationship with Griscelli syndrome. Am. J. Med. Genet. A 2003, 116A, 408–409. [Google Scholar]
  27. Joshi, G.; Pradhan, S.; Mittal, B. Vascular gene polymorphisms (EDNRA-231 G>A and APOE HhaI) and risk for migraine. DNA Cell. Biol. 2011, 30, 577–584. [Google Scholar]
  28. Gupta, R.; Kumar, V.; Luthra, K.; Banerjee, B.; Bhatia, M.S. Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects. J. Headache Pain 2009, 10, 115–120. [Google Scholar]
  29. Pillers, D.A.M.; Kempton, J.B.; Duncan, N.M.; Pang, J.; Dwinnell, S.J.; Trune, D.R. Hearing loss in the laminin-deficient dy mouse model of congenital muscular dystrophy. Mol. Genet. Metab. 2002, 76, 217–224. [Google Scholar] [PubMed]
  30. Hurle, B.; Ignatova, E.; Massironi, S.M.; Mashimo, T.; Rios, X.; Thalmann, I.; Thalmann, R.; Ornitz, D.M. Non-syndromic vestibular disorder with otoconial agenesis in tilted/mergulhador mice caused by mutations in otopetrin 1. Hum. Mol. Genet. 2003, 12, 777–789. [Google Scholar] [PubMed]
  31. McLaren, W.; Gil, L.; Hunt, S.E.; Riat, H.S.; Ritchie, G.R.S.; Thormann, A.; Flicek, P.; Cunningham, F. The Ensembl Variant Effect Predictor. Genome Biol. 2016, 17, 122. [Google Scholar] [PubMed]
  32. Cingolani, P.; Platts, A.; Wang, L.L.; Coon, M.; Nguyen, T.; Wang, L.; Land, S.J.; Lu, X.; Ruden, D.M. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 2012, 6, 80–92. [Google Scholar] [PubMed]
  33. Xia, J.; Benner, M.J.; Hancock, R.E.W. NetworkAnalyst—Integrative approaches for protein–protein interaction network analysis and visual exploration. Nucleic Acids Res. 2014, 42, W167–W174. [Google Scholar]
  34. Breuer, K.; Foroushani, A.K.; Laird, M.R.; Chen, C.; Sribnaia, A.; Lo, R.; Winsor, G.L.; Hancock, R.E.W.; Brinkman, F.S.L.; Lynn, D.J. InnateDB: Systems biology of innate immunity and beyond—Recent updates and continuing curation. Nucleic Acids Res. 2013, 41, D1228–D1233. [Google Scholar] [PubMed]
  35. Lanzi, G.; Balottin, U.; Fazzi, E.; Tagliasacchi, M.; Manfrin, M.; Mira, E. Benign paroxysmal vertigo of childhood: A long-term follow-up. Cephalalgia 1994, 14, 458–460. [Google Scholar]
  36. Buchan, J.G.; Gray, R.S.; Gansner, J.M.; Alvarado, D.M.; Burgert, L.; Gitlin, J.D.; Gurnett, C.A.; Goldsmith, M.I. Kinesin Family Member 6 (kif6) Is Necessary for Spine Development in Zebrafish. Dev. Dyn. 2014, 6, 1646–1657. [Google Scholar]
  37. Roknic, N.; Huber, A.; Hegemann, S.C.A.; Häusler, R.; Gürtler, N. Mutation analysis of Netrin 1 and HMX3 genes in patients with superior semicircular canal dehiscence syndrome. Acta Otolaryngol. 2012, 132, 1061–1065. [Google Scholar]
  38. Techlo, T.R.; Rasmussen, A.H.; Møller, P.L.; Bøttcher, M.; Winther, S.; Davidsson, O.B.; Olofsson, I.A.; Chalmer, M.A.; Kogelman, L.J.A.; Nyegaard, M.; et al. Familial analysis reveals rare risk variants for migraine in regulatory regions. Neurogenetics 2020, 21, 149–157. [Google Scholar]
  39. Tu, Y.H.; Cooper, A.J.; Teng, B.; Chang, R.B.; Artiga, D.J.; Turner, H.N.; Mulhall, E.M.; Ye, W.; Smith, A.D.; Liman, E.R. An evolutionarily conserved gene family encodes proton-selective ion channels. Science 2018, 359, 1047–1050. [Google Scholar]
  40. Skuladottir, A.T.; Bjornsdottir, G.; Nawaz, M.S.; Petersen, H.; Rognvaldsson, S.; Moore, K.H.S.; Olafsson, O.A.; Sigurdardottir, G.R.; Saevarsdottir, S.; Ivarsdottir, E.V.; et al. A genome-wide meta-analysis uncovers six sequence variants conferring risk of vertigo. Commun. Biol. 2021, 4, 1148. [Google Scholar]
  41. Simoneau, M.; Lamothe, V.; Hutin, E.; Mercier, P.; Teasdale, N.; Blouin, J. Evidence for cognitive vestibular integration impairment in idiopathic scoliosis patients. BMC Neurosci. 2009, 10, 102. [Google Scholar] [CrossRef] [PubMed]
  42. Guo, X.; Chau, W.W.; Hui-Chan, C.W.Y.; Cheung, C.S.K.; Tsang, W.W.N.; Cheng, J.C.Y. Balance control in adolescents with idiopathic scoliosis and disturbed somatosensory function. Spine J. 2006, 31, 437–440. [Google Scholar]
  43. Miller, N.D.; Nance, M.A.; Wohler, E.S.; Hoover-Fong, J.E.; Lisi, E.; Thomas, G.H.; Pevsner, J. Molecular (SNP) Analyses of Overlapping Hemizygous Deletions of 10q25. 3 to 10qter in Four Patients: Evidence for HMX2 and HMX3 as Candidate Genes in Hearing and Vestibular Function. Am. J. Med. Genet. A 2009, 149A, 669–680. [Google Scholar]
  44. Oliveira, J.; Gruber, A.; Cardoso, M.; Taipa, R.; Fineza, I.; Gonçalves, A.; Laner, A.; Winder, T.L.; Schroeder, J.; Rath, J.; et al. LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes. Hum. Mutat. 2018, 39, 1314–1337. [Google Scholar]
  45. Geranmayeh, F.; Clement, E.; Feng, L.H.; Sewry, C.; Pagan, J.; Mein, R.; Abbs, S.; Brueton, L.; Childs, A.M.; Jungbluth, H.; et al. Neuromuscular Disorders Genotype—Phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul. Disord. 2010, 20, 241–250. [Google Scholar]
  46. Schmahmann, J.D.; Weilburg, J.B.; Sherman, J.C. The neuropsychiatry of the cerebellum—Insights from the clinic. Cerebellum 2007, 6, 254–267. [Google Scholar]
  47. Kayan, A.; Hood, J.D. Neuro-otological Manifestations of Migraine. Brain 1984, 107, 1123–1142. [Google Scholar] [CrossRef]
  48. Neuhauser, H.; Leopold, M.; von Brevern, M.; Arnold, G.; Lempert, T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001, 56, 436–441. [Google Scholar] [CrossRef]
  49. Neuhauser, H.K.; von Brevern, M.; Radtke, A.; Lezius, F.; Feldmann, M.; Ziese, T.; Lempert, T. Epidemiology of vestibular vertigo: A neurotologic survey of the general population. Neurology 2005, 65, 898–904. [Google Scholar]
  50. Cavestro, C.; Mandrino, S. Thrombophilic disorders in migraine. Front. Neurol. 2014, 5, 120. [Google Scholar] [CrossRef]
  51. Tietjen, G.E.; Collins, S.A. Hypercoagulability and Migraine. Headache 2018, 58, 173–183. [Google Scholar] [PubMed]
  52. Fattori, B.; Nacci, A.; Casani, A.; Cristofani, R.; Sagripanti, A. Hemostatic alterations in patients with acute, unilateral vestibular paresis. Otolaryngol. Head Neck Surg. 2001, 124, 401–407. [Google Scholar] [CrossRef] [PubMed]
  53. Skarp, S.; Kanervo, L.; Kotimäki, J.; Sorri, M.; Männikkö, M.; Hietikko, E. Whole-exome sequencing suggests multiallelic inheritance for childhood-onset Ménière’s disease. Ann. Hum. Genet. 2019, 83, 389–396. [Google Scholar] [CrossRef] [PubMed]
  54. Martín-Sierra, C.; Gallego-Martinez, A.; Requena, T.; Frejo, L.; Batuecas-Caletrío, A.; Lopez-Escamez, J.A. Variable expressivity and genetic heterogeneity involving DPT and SEMA3D genes in autosomal dominant familial Meniere’s disease. Eur. J. Hum. Genet. 2017, 25, 200–207. [Google Scholar]
  55. Roman-Naranjo, P.; Gallego-Martinez, A.; Soto-Varela, A.; Aran, I.; Moleon, M.D.C.; Espinosa-Sanchez, J.M.; Amor-Dorado, J.C.; Batuecas-Caletrio, A.; Perez-Vazquez, P.; Lopez-Escamez, J.A. Burden of rare variants in the OTOG gene in Familial Meniere’s Disease. Ear. Hear. 2020, 41, 1598–1605. [Google Scholar]
  56. Roman-Naranjo, P.; Moleon, M.D.C.; Aran, I.; Escalera-Balsera, A.; Soto-Varela, A.; Bächinger, D.; Gomez-Fiñana, M.; Eckhard, A.H.; Lopez-Escamez, J.A. Rare coding variants involving MYO7A and other genes encoding stereocilia link proteins in familial Meniere Disease. Hear. Res. 2021, 409, 108329. [Google Scholar]
  57. Kentala, E.; Rauch, S.D. A practical assessment algorithm for diagnosis of dizziness. Otolaryngol. Head Neck Surg. 2003, 128, 54–59. [Google Scholar]
Genes 14 00831 g001 550
Figure 1. Subnetwork connecting genes with rare variants identified in pediatric patients with peripheral vestibular dysfunction. Red and yellow nodes indicate input genes (Table 2). CARF is included in the subnetwork though not labelled in the figure.
Figure 1. Subnetwork connecting genes with rare variants identified in pediatric patients with peripheral vestibular dysfunction. Red and yellow nodes indicate input genes (Table 2). CARF is included in the subnetwork though not labelled in the figure.
Genes 14 00831 g001
Genes 14 00831 g002 550
Figure 2. Gel image of RT-PCR products showing strong expression of HMX3 and LAMA2 in human vestibular tissues. (-)C: negative control; +C: positive control; 1 and 2: patients 1 and 2; ACTB: β-actin.
Figure 2. Gel image of RT-PCR products showing strong expression of HMX3 and LAMA2 in human vestibular tissues. (-)C: negative control; +C: positive control; 1 and 2: patients 1 and 2; ACTB: β-actin.
Genes 14 00831 g002
Table
Table 3. Top pathways per database from network analysis of candidate genes identified for pediatric vestibular disorders.
Table 3. Top pathways per database from network analysis of candidate genes identified for pediatric vestibular disorders.
PANTHER (Biological Processes)Gene Ontology (Biological Processes)REACTOME
PathwayFDR-adj-pPathwayFDR-adj-pPathwayFDR-adj-p
Receptor-mediated
endocytosis		2.60 × 10–7Vesicle-mediated transport1.19 × 10–10Activation of BH3-only proteins8.86 × 10–13
Regulation of binding8.70 × 10–6Coagulation1.71× 10–10Intrinsic pathway for apoptosis1.33 × 10–10
Protein targeting2.10 × 10–5Transcription initiation from RNA polymerase II promoter4.07 × 10–10Translocation of GLUT4
to the plasma membrane		6.39 × 10–10
Viral process2.20 × 10–5Blood coagulation6.91 × 10–10Activation of BAD and
translocation to mitochondria		3.11 × 10–9
Negative regulation of apoptotic process6.30 × 10–5Hemostasis8.77 × 10–10Membrane trafficking1.11 × 10–8
Chemical synaptic
transmission		1.30 × 10–4Regulation of body
fluid levels		2.59 × 10–9Hemostasis4.02 × 10–8
Cholesterol metabolic
process		1.10 × 10–3Wound healing5.08 × 10–9Platelet degranulation9.93 × 10–7
Endocytosis2.90 × 10–3DNA-dependent
transcription, initiation		5.30 × 10–9Platelet activation, signaling,
and aggregation		1.29 × 10–6
Heart development4.30 × 10–3Exocytosis1.64 × 10–8Insulin processing1.32 × 10–6
Vitamin metabolic process4.50 × 10–3Cell morphogenesis involved in differentiation1.71 × 10–8Response to elevated platelet cytosolic Ca2+1.65 × 10–6
Protein localization1.26 × 10–6
Pathways that are identified in multiple databases are underlined.
Table
Table 4. Rare variants in Spanish probands with Meniere’s disease.
Table 4. Rare variants in Spanish probands with Meniere’s disease.
IDGeneVariantHighest MAFDamaging PredictionScaled CADD
S19ECM1c.844C>T (p.(Arg282Trp)(AU)Lat: 1.3 × 10–4PR, SI24.6
60OTOP1c.380A>T (p.(His127Leu))(AU)Eur: 7.3 × 10–5PP, MT22.8
9OTOP2c.760G>A (p.(Ala254Thr))(AU)Afr: 2.2 × 10–4PP, MT23.6
Abbreviations: Afr: African; (AU): All of Us database; CADD: Combined Annotation-Dependent Depletion; Eur: European; Lat: Latin American; MAF: minor allele frequency; MT: MutationTaster; PP: PolyPhen2; PR: PROVEAN; SI: SIFT.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sumalde, A.A.M.; Scholes, M.A.; Kalmanson, O.A.; Terhune, E.A.; Frejo, L.; Wethey, C.I.; Roman-Naranjo, P.; Carry, P.M.; Gubbels, S.P.; Lopez-Escamez, J.A.; et al. Rare Coding Variants in Patients with Non-Syndromic Vestibular Dysfunction. Genes 2023, 14, 831. https://doi.org/10.3390/genes14040831

AMA Style

Sumalde AAM, Scholes MA, Kalmanson OA, Terhune EA, Frejo L, Wethey CI, Roman-Naranjo P, Carry PM, Gubbels SP, Lopez-Escamez JA, et al. Rare Coding Variants in Patients with Non-Syndromic Vestibular Dysfunction. Genes. 2023; 14(4):831. https://doi.org/10.3390/genes14040831

Chicago/Turabian Style

Sumalde, Angelo Augusto M., Melissa A. Scholes, Olivia A. Kalmanson, Elizabeth A. Terhune, Lidia Frejo, Cambria I. Wethey, Pablo Roman-Naranjo, Patrick M. Carry, Samuel P. Gubbels, Jose A. Lopez-Escamez, and et al. 2023. "Rare Coding Variants in Patients with Non-Syndromic Vestibular Dysfunction" Genes 14, no. 4: 831. https://doi.org/10.3390/genes14040831

APA Style

Sumalde, A. A. M., Scholes, M. A., Kalmanson, O. A., Terhune, E. A., Frejo, L., Wethey, C. I., Roman-Naranjo, P., Carry, P. M., Gubbels, S. P., Lopez-Escamez, J. A., Hadley-Miller, N., & Santos-Cortez, R. L. P. (2023). Rare Coding Variants in Patients with Non-Syndromic Vestibular Dysfunction. Genes, 14(4), 831. https://doi.org/10.3390/genes14040831

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop